Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 UPM Pharmaceuticals Appoints COO | Contract Pharma
Breaking News, Promotions & Moves

UPM Pharmaceuticals Appoints COO

Curtin was promoted from his previous role as executive vice president of Quality Operations

UPM Pharmaceuticals, a CDMO focused on solid oral and semi-solid dosage forms, has appointed Chris Curtin as chief operating officer. This comes as a promotion from his previous role as executive vice president of Quality Operations. Mr. Curtin will lead the organization responsible for Research & Development, Manufacturing, Quality Assurance, Inventory Management, Quality Control and Analytical Services.

 

Jim Gregory, chief executive officer of UPM Pharmaceuticals, stated “Chris brings a tremendous amount of industry experience and expertise.  We feel strongly that Chris is perfectly positioned to lead UPM into the next phase of growth. Chris has been instrumental in putting quality processes in place across the organization and we are confident that under his guidance, UPM will continue to grow and strive for excellence.”

 

Mr. Curtin has held executive management positions at Parke-Davis/Warner Lambert, King Pharmaceuticals, Graceway Pharmaceuticals, Rockward Pharmaceutical Consultants, Actient Pharmaceuticals and more recently Lynwood Pharmaceuticals. 

 

“In my role as COO I look forward to enhancing UPM’s presence and marketability in the CDMO space by utilizing the talents and technical skills of all our UPM colleagues to enhance systems, processes and capabilities,” Mr. Curtin said.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters